Why Test for HIV and Hepatitis C When Diagnosing ITP?

Doctors test for HIV and Hepatitis C when evaluating Immune Thrombocytopenia (ITP) because these viruses can cause your immune system to destroy your platelets. When a known condition or infection triggers your immune system to attack your platelets, it is called secondary ITP ^[1]. Because ITP is a “diagnosis of exclusion,” doctors must look for these potential viral triggers as part of a standard evaluation ^[1][2].

Reassurance: These tests are a routine part of evaluating newly discovered low platelets. Ordering them does not mean your doctor thinks you acquired an infection or engaged in risky behavior. They are recommended for most patients regardless of symptoms or risk factors ^[3][2].

Urgent Safety Warning: If you experience uncontrolled bleeding, vomiting blood, black or bloody stools, a severe new headache, neurological symptoms, or bleeding after a head injury, seek urgent medical evaluation. Do not delay care for serious bleeding symptoms.

Primary vs. Secondary ITP

Understanding why infectious disease testing is standard requires knowing the difference between the two main classifications of the disorder:

• Primary ITP: Diagnosed when you have low platelets due to an overactive immune system, but there is no identifiable underlying disease or trigger causing it ^[1].
• Secondary ITP: Occurs when another condition—such as a viral infection, an autoimmune disease, or a medication—is actively provoking the immune system into targeting platelets ^[1][4].

It is important to know that negative HIV and Hepatitis C tests do not automatically confirm primary ITP. Identifying primary ITP requires your doctor to look at the overall picture, including a complete blood count (CBC), a review of your blood smear under a microscope, your medical history, and an assessment of your medications and other potential causes ^[1][5].

How Viruses Affect Platelets

Viruses like HIV and Hepatitis C (HCV) can be present without obvious symptoms and can cause low platelets through multiple pathways:

• Immune System Confusion (Molecular Mimicry): It is believed that proteins on the surface of some viruses look similar to proteins on your platelets. When your immune system creates antibodies to fight the virus, those antibodies may mistakenly cross-react and destroy your healthy platelets instead ^[6][7].
• Decreased Platelet Production: These viruses, and your body’s immune response to them, can also suppress your bone marrow’s ability to produce new platelets ^[7][8].
• Other Overlapping Causes: In patients with HIV or HCV, low platelets might not be purely an immune attack. They can also result from liver disease, an enlarged spleen (which traps platelets), opportunistic infections, or the medications used to treat other conditions ^[9][10].

Note: Other infections, such as Helicobacter pylori (a bacteria in the stomach), are also associated with ITP in some patients, though testing for it depends on regional guidelines and your doctor’s specific assessment ^[1].

What the Tests Mean for Your Treatment

Identifying an underlying virus completely changes how your low platelets are managed.

If you have primary ITP, common initial treatments include corticosteroids (like prednisone) to suppress the immune system, or intravenous immunoglobulin (IVIG), an immune-modulating treatment used when a rapid platelet rise is needed ^[11].

If your low platelets are related to HCV or HIV, treating the infection is a priority.

• For Hepatitis C, curing the virus with modern direct-acting antiviral therapy can improve and sometimes normalize platelet counts in many patients ^[12][6]. However, improvement is not guaranteed, and low platelets may persist if there is liver scarring or a separate ITP process ^[13].
• For HIV, managing the virus with standard antiretroviral therapy significantly reduces the chances of severe thrombocytopenia ^[14].

Even if a virus is found, corticosteroids, IVIG, or other ITP-directed treatments may still be used if you have severe bleeding or need a rapid increase in platelets. Your care team will individualize your treatment, balancing the need to control the infection with the need to prevent bleeding.

Finally, a positive screening test for HIV or Hepatitis C is not a final diagnosis. A reactive screening result always requires confirmatory testing, such as an HCV RNA test to confirm a current, active Hepatitis C infection.